Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.

Saved in:
Bibliographic Details
Title: Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.
Authors: Rasmussen TA; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Infectious Diseases, Aarhus University Hospital, AarhusDenmark., Ahuja SK; Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA., Kuwanda L; The Kirby Institute, University of New South Wales, Sydney, Australia., Vjecha MJ; Institute for Clinical Research, Inc., Veterans Affairs Medical Center, Washington D.C., USA., Hudson F; MRC Clinical Trials Unit at UCL, London UK Uganda Virus Research Institute/MRC, London, United Kingdom.; LSHTM Uganda Research Unit, HIV Intervention Programme, Entebbe, Uganda., Lal L; Burnet Institute, MelbourneAustralia., Rhodes A; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Chang J; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Palmer S; Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia., Auberson-Munderi P; UNAIDS, HIV Prevention, Geneva, Switzerland., Mugerwa H; Joint Clinical Research Centre, Entebbe, Uganda., Wood R; The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Badal-Faesen S; Clinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa., Pillay S; Enhancing Care Foundation, Department of Research and Post-graduate Support, Durban University of Technology, Durban, South Africa., Mngqibisa R; Enhancing Care Foundation, Department of Research and Post-graduate Support, Durban University of Technology, Durban, South Africa., LaRosa A; Asociación Civil Impacta Salud y Educación, Lima, Perú., Hildago J; Via Libre, Lima, Perú., Petoumenos K; The Kirby Institute, University of New South Wales, Sydney, Australia., Chiu C; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Lutaakome J; LSHTM Uganda Research Unit, HIV Intervention Programme, Entebbe, Uganda.; Uganda Virus Research Institute/MRC, Entebbe, Uganda., Kitonsa J; LSHTM Uganda Research Unit, HIV Intervention Programme, Entebbe, Uganda.; Uganda Virus Research Institute/MRC, Entebbe, Uganda., Kabaswaga E; Joint Clinical Research Centre, Entebbe, Uganda., Pala P; Immunova Limited, London, United Kingdom., Ganoza C; Asociación Civil Impacta Salud y Educación, Lima, Perú.; Universidad Peruana Cayetano Heredia, Lima, Perú., Fisher K; Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia., Chang C; The Kirby Institute, University of New South Wales, Sydney, Australia.; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Central Clinical School, Monash University, Infectious Diseases, Melbourne, Australia.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia., Lewin SR; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Wright EJ; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Burnet Institute, MelbourneAustralia.; Central Clinical School, Monash University, Infectious Diseases, Melbourne, Australia.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Nov 14; Vol. 75 (10), pp. 1781-1791.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciac249